Pharmacist Intervention a
Study Author/Date	1	2	3	4 b	5	6	7	8	9	10 c	11	12	13	14	15
Al-Rashed et al., 200258							●							●
Barker et al., 201237										H	●	●			●
Bolas et al., 200438	●	●			●	●	●	●	●						●
Dudas et al., 200136										T	●
Englander et al., 20146				1	●	●									●
Farris et al., 201459	●				●	●	●	●	●	T	●	●		●
Gillespie et al., 200910	●	●	●	3	●		●	●	●	T			●
Gwadry-Sridhar et al., 200512				2	●			●
Hawes et al., 201460										C
Holland et al., 200539										H	●	●			●
Holland et al., 200740										H	●	●			●
Jack et al., 200941										T	●
Koehler et al., 200942	●			3	●	●	●		●	T
Kripalani et al., 201213	●			2	●		●	●		T	●		●	●
Lipton and Bird, 199443							●			T	●	●
Lisby et al., 201044	●			1
López Cabezas et al., 200645							●			T
Makowsky et al., 200946	●		●	3		●	●	●	●
Naunton et al., 200347										H	●			●
Nazareth et al., 200148						●	●	●	●	H	●		●
Rainville, 199949			●	3	●					T		●
Schmader et al., 200450			●	3
Schnipper et al., 200651				3		●	●			T	●
Schnipper et al., 200952	●			3
Scullin et al., 200753	●	●		3	●	●	●	●	●				●		●
Spinewine et al., 200711	●		●	1			●		●
Stewart et al., 199854										H	●		●	●
Stewart et al., 199855										H	●		●	●
Stowasser et al., 200256	●					●			●
Triller et al., 200757										H	●	●

^a Pharmacist intervention; number according to the pharmacist intervention model (Table 1).

^b Medication review levels: 1 = prescription review, 2 = adherence support review (with patient present), 3 = clinical review, 4 = clinical review with prescribing.

^c Patient-centered follow-up: C = clinic visit, H = home visit, T = telephone call.